A clinician survey for management of the secondary immunodeficiency caused by hematological malignancies in China.

ABSTRACT:

Abstract

Unlike Western countries, there are still few clinical immunology specialists in China, and the optimal care for secondary immunodeficiency caused by hematological malignancies is unknown. Therefore, we initiated this clinician survey study to describe the current situation of the care for malignancy patients with hypogammaglobulinemia in China.We adapted a previously published online questionnaire of current clinical practices regarding the management of secondary immunodeficiency caused by hematological malignancies and then distributed the questionnaire to 52 hematologists in China via WeChat mobile software; the survey collected demographic details, starting dosage, target immunoglobulin (Ig) level, monitoring, criteria for stopping Ig replacement, vaccination use, and

SUBMITTER: Ye C 

PROVIDER: S-EPMC7837821 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature